Air Transportation of the COVID-19 Vaccines

ICR 202201-2120-001

OMB: 2120-0804

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
IC Document Collections
ICR Details
202201-2120-001
Received in OIRA
DOT/FAA Ready for OST Review
Air Transportation of the COVID-19 Vaccines
New collection (Request for a new OMB Control Number)   No
Emergency 02/11/2022
02/01/2022
  Requested Previously Approved
6 Months From Approved
39 0
195 0
17,275 0

In accordance with the Paperwork Reduction Act of 1995, the FAA invites public comments about its intention to request the Office of Management and Budget (OMB) grant emergency approval for a new information collection. The Federal Register Notice with a 60-day comment period soliciting comments is waived, as this is an emergency action in response to the COVID-19 public health emergency. This action would enable the FAA to collect voluntary information from air carriers authorized to conduct operations under Parts 121 and 135 of Title 14 of the Code of Federal Regulations (14 CFR) that participate or have participated in transport of the COVID-19 vaccines to support continued operational safety and efficiency.
The Federal Aviation Administration (FAA) seeks emergency clearance from the Office of Management and Budget (OMB) for a new information collection in connection with the FAA COVID-19 Vaccine Air Transport Team’s work with air carriers and other aviation stakeholders to aid in the safe and efficient transport of the COVID-19 vaccines. This action would enable the FAA to collect voluntary information from air carriers authorized to conduct operations under Parts 121 and 135 of Title 14 of the Code of Federal Regulations (14 CFR) that participate or have participated in transport of the COVID-19 vaccines. The targeted audience and sample frame for this information collection are air carriers authorized to operate under Parts 121 and 135 that registered to participate in the DOT/FAA-hosted Vaccine Distribution Engagement Meetings (VDEMs), which are described in more detail below, and others such air carriers that are members of industry associations who registered to participate in the VDEMs. Impacting millions of lives, transport of the COVID-19 vaccines is one of the most logistically complicated endeavors undertaken. The vaccines continue to be transported, and additional transportation needs are anticipated during both the current and potential future waves of the COVID-19 pandemic. Lessons learned from transport of the vaccines also will inform future responses to public health emergencies, as applicable.

US Code: 49 USC 44701 Name of Law: Transportation, General requirements
  
None

Not associated with rulemaking
Other Documents for OIRA Review

No

1
IC Title Form No. Form Name
Air Transportation of the COVID-19 Vaccines

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 39 0 0 39 0 0
Annual Time Burden (Hours) 195 0 0 195 0 0
Annual Cost Burden (Dollars) 17,275 0 0 17,275 0 0
Yes
Miscellaneous Actions
No
This is a new collection.

No
    No
    No
No
No
No
Yes
Victoria Lehman 202 236-5776 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
02/01/2022


© 2024 OMB.report | Privacy Policy